NVO

Novo Nordisk ADR

Feb 26 • 04:00PM ET

37.62

-0.54 -1.42 %

Healthcare • Drug Manufacturers - General • Denmark • NYSE

Peers: LLY MRK ABBV JNJ AMGN AZN-D PFE SNY BMY GSK

| Held by: PVAL PPH AVDE FTHI WCMI PID PINK OZEM AQEC APIE

Index	-	P/E	10.85	EPS (ttm)	3.47	Insider Own	0.01%	Shs Outstand	3.37B	Perf Week	-22.35%
Market Cap	126.75B	Forward P/E	11.07	EPS next Y	3.40	Insider Trans	0.00%	Shs Float	3.37B	Perf Month	-40.18%
Enterprise Value	143.10B	PEG	15.37	EPS next Q	0.82	Inst Own	9.45%	Short Float	0.94%	Perf Quarter	-16.34%
Income	15.45B	P/S	2.71	EPS this Y	-7.88%	Inst Trans	-0.10%	Short Ratio	1.41	Perf Half Y	-32.02%
Sales	46.77B	P/B	5.48	EPS next Y	1.43%	ROA	20.59%	Short Interest	31.69M	Perf YTD	-26.06%
Book/sh	6.87	P/C	29.90	EPS next 5Y	0.72%	ROE	61.25%	52W High	91.90 -59.06%	Perf Year	-57.99%
Cash/sh	1.26	P/FCF	14.16	EPS past 3/5Y	26.28% 20.36%	ROIC	31.38%	52W Low	37.65 -0.08%	Perf 3Y	-46.86%
Dividend Est.	1.68 (4.45%)	EV/EBITDA	6.33	Sales past 3/5Y	23.19% 19.21%	Gross Margin	80.90%	Volatility	2.29% 3.49%	Perf 5Y	5.60%
Dividend TTM	1.73 (4.59%)	EV/Sales	3.06	EPS Y/Y TTM	5.57%	Oper. Margin	41.17%	ATR (14)	2.25	Perf 10Y	44.75%
Dividend Ex-Date	Mar 30, 2026	Quick Ratio	0.57	Sales Y/Y TTM	11.11%	Profit Margin	33.03%	RSI (14)	24.12	Recom	2.47
Dividend Gr. 3/5Y	28.28% 20.66%	Current Ratio	0.80	EPS Q/Q	3.95%	SMA20	-21.65%	Beta	0.70	Target Price	53.01
Payout	38.07%	Debt/Eq	0.67	Sales Q/Q	0.66%	SMA50	-28.41%	Rel Volume	1.55	Prev Close	38.16
Employees	68794	LT Debt/Eq	0.61	Earnings	Feb 04 BMO	SMA200	-34.36%	Avg Volume	22.55M	Price	37.62
IPO	Apr 30, 1981	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.40% 3.10%	Trades		Volume	34,923,507	Change	-1.42%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-24-26	Downgrade	Kepler	Buy → Hold
Feb-24-26	Downgrade	JP Morgan	Overweight → Neutral
Feb-23-26	Downgrade	Deutsche Bank	Buy → Hold
Feb-12-26	Upgrade	Jefferies	Underperform → Hold
Jan-27-26	Initiated	Citigroup	Neutral
Dec-08-25	Downgrade	Argus	Buy → Hold
Oct-27-25	Resumed	Jefferies	Underperform
Oct-01-25	Upgrade	HSBC Securities	Hold → Buy
Sep-29-25	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$47
Sep-17-25	Upgrade	Berenberg	Hold → Buy
Sep-16-25	Upgrade	Rothschild & Co Redburn	Neutral → Buy
Sep-09-25	Upgrade	Bernstein	Mkt Perform → Outperform
Aug-13-25	Upgrade	BNP Paribas Exane	Underperform → Neutral	$54
Aug-05-25	Downgrade	UBS	Buy → Neutral
Jul-31-25	Downgrade	HSBC Securities	Buy → Hold	$57
Jul-30-25	Downgrade	Barclays	Overweight → Equal Weight
Apr-17-25	Downgrade	BMO Capital Markets	Outperform → Market Perform	$64
Mar-13-25	Upgrade	Kepler	Hold → Buy
Mar-03-25	Downgrade	Stifel	Buy → Hold
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight

Show Previous Ratings

Feb-26-26 12:59PM	Eli Lilly's New Oral Weight Loss Drug Outperforms Semaglutide, Eyes Potential US Approval In Q2 (Benzinga)
09:56AM	Jim Cramer Recommends Eli Lilly over Novo Nordisk (Insider Monkey)
08:30AM	Novavax, Inc. Q4 2025 Earnings Call Summary (Moby)
07:39AM	For the first time in decades, new hair-loss treatments are in the works. Heres how theyre different. (MarketWatch)
07:10AM	Lillys GLP-1 pill tops Novos Rybelsus in head-to-head trial (BioPharma Dive)
06:42AM	Loading…
06:42AM	Anthropic Excites But Doesn't Replace (GuruFocus.com)
05:44AM	Novo Nordisk and Vivtex collaborate for oral medicines development (Pharmaceutical Business Review)
Feb-25-26 11:31PM	Novo Nordisk's China Obesity Drug Cuts Nearly One-Fifth Of Body Weight (Benzinga)
03:36PM	For the first time in decades, new hair-loss treatments are in the works. Here's how they're different. (MarketWatch)
01:42PM	Ozempic, Wegovy list prices to be slashed by up to 50% (NY Daily News)
01:01PM	Novo Partners Vivtex in Deal Worth Up to $2.1 Billion (GuruFocus.com)
12:47PM	Novo Nordisk Strikes Up to $2.1B Vivtex Deal for Oral Obesity Drugs (GuruFocus.com)
11:33AM	Novo Nordisk's 40% Fall May Be Creating A Deep-Value Moment (Benzinga)
11:00AM	Wedbush says Anthropic demos strong, software-replacement hype overdone (TipRanks)
10:41AM	BofA sees limited impact to Eli Lillys franchise from Novos GLP-1 price update (TipRanks)
09:28AM	Loading…
09:28AM	Novo Nordisk Licenses Vivtex Tech for Up to $2.1 Billion to Deepen Obesity Push (The Wall Street Journal)
09:13AM	Ozempic Price War - Novo Nordisk Slashes Prices By 50% (Benzinga)
08:53AM	Novo Nordisk, Vivtex to Develop Obesity Drugs in Deal Valued at Up to $2.1 Billion (The Wall Street Journal)
08:40AM	Lilly's GLP-1 Blockbusters Drive 2025 Revenue Surge: What's Ahead? (Zacks)
08:01AM	Novo Nordisk's Loss Is Eli Lilly's Gain (Benzinga)
07:08AM	Novo Nordisk Cuts Wegovy Prices in Half While Its Stock Sits Near a 52-Week Low (24/7 Wall St.)
04:14AM	Novo Nordisk To Slash GLP-1 Drug Prices By Up To 50% In US Starting 2027 (Benzinga)
03:00AM	With Vivtex deal, Novo gains a chance at better oral obesity drugs (BioPharma Dive)
Feb-24-26 05:18PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:35PM	These Stocks Are Todays Movers: AMD, Hims & Hers, Keysight, IBM, Kratos, Vir Biotechnology, Whirlpool, and More (Barrons.com)
03:35PM	Eli Lilly Falls After Novo Nordisk Price Cuts (GuruFocus.com)
03:32PM	Novo Warns Sales Will Drop as Zepbound Overtakes Wegovy (GuruFocus.com)
02:48PM	Novo Nordisk Unveils Up to 50% US Price Cut for Wegovy, Ozempic (GuruFocus.com)
02:47PM	Eli Lilly Drops After Novo Nordisk Unleashes Massive GLP-1 Price Cuts (GuruFocus.com)
02:19PM	Novo Nordisk to Cut U.S. List Prices for Ozempic, Wegovy by Up to 50% (The Wall Street Journal)
01:31PM	Loading…
01:31PM	Novo Nordisk to slash list prices of Ozempic, Wegovy by up to 50% (Fox Business)
12:03PM	Anthropic's enterprise showcase impressed the room but is the AI threat to software stocks remains largely a ghost story? (Proactive)
12:00PM	Lilly vs. Novo Nordisk: Obesity Drug Giants' Face-Off in 2026 (Zacks)
11:31AM	Anthropic Mends Fences At Enterprise Event. Software Stocks Gain. (Investor's Business Daily)
10:43AM	Novo Nordisk, Eli Lilly Stocks Drop on Wegovy Maker's Price-Cut Plan (The Wall Street Journal)
10:24AM	Novo Nordisk to halve US list price of Wegovy from 2027 (Reuters Videos)
10:09AM	Hims & Hers Stock Drops. Why Earnings Are Underwhelming Investors. (Barrons.com)
10:08AM	Novo Nordisk to slash Wegovy and Ozempic prices starting in 2027 (CBS News)
09:58AM	Stocks to Watch Tuesday: Home Depot, Hims & Hers, Whirlpool (The Wall Street Journal)
09:55AM	Meta, AMD announce chip partnership, Novo Nordisk cuts US GLP-1 prices (Yahoo Finance Video)
09:18AM	Stock in Rivals Novo Nordisk and Eli Lilly Slips (The Wall Street Journal)
09:15AM	Novo Nordisk downgraded by leading banks as CagriSema trial flops against Zepbound (Proactive)
09:14AM	Novo Nordisk to slash prices of weightloss drugs in US (AFP)
09:02AM	Novo Nordisk halves US price of weight-loss drug (Financial Times)
08:13AM	Eli Lilly falls 2% on Novo Nordisk price cut plans (Investing.com)
08:01AM	Novo to cut Ozempic and Wegovy prices amid intense competition (USA TODAY)
07:53AM	Stocks to Watch Tuesday: FedEx, Home Depot, Novo Nordisk (The Wall Street Journal)
07:51AM	Novo Nordisk and Eli Lilly shares both fall after Ozempic price-cut plan (MarketWatch)
07:48AM	Novo Nordisk Is Cutting Ozempic and Wegovy Prices. The Stock Is Still Slumping. (Barrons.com)
07:22AM	Company News for Feb 24, 2026 (Zacks)
06:40AM	Hims & Hers Snaps EPS Losing Streak but Shares Still in Free Fall (24/7 Wall St.)
06:00AM	Novo Nordisk's China Obesity Drug Cuts Nearly One-Fifth Of Body Weight (Benzinga)
05:22AM	Novo Nordisk, United Laboratories Say New Obesity Drug Helps Patients Lose Weight in Trial (The Wall Street Journal)
05:19AM	Novo Nordisk selloff continues as stock gets hit with rating downgrades (Investing.com)
04:12AM	Analyst says he's thrown in the towel on Novo Nordisk after latest setback (MarketWatch)
Feb-23-26 08:18PM	Hims & Hers Health, Novo Nordisk, PayPal, Uber And BWX Technologies: Why These 5 Stocks Are On Investors' Radars Today (Benzinga) -16.43%
06:49PM	Hims & Hers Health Fourth-Quarter Sales Rise, Gives Soft First-Quarter Guidance (The Wall Street Journal)
05:33PM	Stocks to Watch Monday Recap: Diamondback, Netflix, Novo Nordisk, Lilly (The Wall Street Journal)
05:17PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:40PM	Stock Market Today: Dow Sinks As EU Makes Trump Tariff Move; IBM Dives On This AI Threat (Live Coverage) (Investor's Business Daily)
04:27PM	These Stocks Are Todays Movers: Novo Nordisk, Lilly, PayPal, Arcellx, CrowdStrike, KKR, Strategy, and More (Barrons.com)
04:25PM	Hims & Hers Stock Falls. Why Earnings Are Underwhelming Investors. (Barrons.com)
04:11PM	Novo Nordisk Dives As Next-Gen Obesity Drug Lags Eli Lilly's Kingpin (Investor's Business Daily)
03:32PM	Why Novo Nordisk Stock Is Plungingand Why Its Good News for Eli Lilly (Barrons.com)
03:20PM	Reliance Q4 Earnings Call Highlights (MarketBeat)
03:13PM	Stock Market Today: Dow Dives, Cybersecurity Plays Hit As Software Sinks; Gold Stocks Shine (Live Coverage) (Investor's Business Daily)
02:30PM	Nasdaq, Dow Jones start the week lower as Trump resets tariffs (Proactive)
02:29PM	Viking Therapeutics Stock Gains Amid Obesity Drug Buzz (Benzinga)
02:03PM	Stock Market Today: Dow Skids As EU Makes Trump Tariff Move; These Gold Stocks Shine (Live Coverage) (Investor's Business Daily)
01:50PM	Stocks to Watch Monday: Merck, Netflix, Novo Nordisk, Eli Lilly (The Wall Street Journal)
01:10PM	Novo Nordisk Trips in the Obesity Race (Moby)
01:01PM	Novo Nordisk Shares Drop 15% After CagriSema Misses Phase 3 Goal (GuruFocus.com)
12:57PM	Novo Nordisk shares sink after weight loss drug fails to match Eli Lilly's in trial (CNBC TV)
12:44PM	Novo Next-Generation Obesity Shot Falls Short of Lilly Rival (Bloomberg)
12:34PM	Stock Market Today: Dow Dives As EU Makes Trump Tariff Move; Novo Plunges On This (Live Coverage) (Investor's Business Daily)
11:55AM	Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out (Reuters)
11:44AM	Novo Nordisk Shares Plunge After Obesity Drug Fails to Beat Zepbound (The Wall Street Journal)
11:42AM	Novo Nordisk's Loss Is Eli Lilly's Gain (Benzinga)
11:35AM	Novo Nordisk Tumbles in 'Worst Case Scenario': Next-Gen Weight Loss Drug Underperforms (Benzinga)
11:32AM	Stock Of The Day: Breakdown In Novo Nordisk? (Benzinga)
11:15AM	Trump puts pressure on Netflix board, Domino's stock rises on Q4 (Yahoo Finance Video)
11:10AM	Novo Nordisk Sinks, Lilly Surges After Obesity Drug Trial Shock (GuruFocus.com)
11:08AM	Novo Nordisk Stock Tumbles Monday to Its Lowest Point in Nearly 5 Years. Here's Why (Investopedia)
10:35AM	Novo Nordisk Stock Suffers After Weight Loss Drug Underperformance (Schaeffer's Research)
10:33AM	Nvidia, Joby, CoreWeave, Lucid and More Stocks with Earnings This Week (Benzinga)
09:56AM	Dr. Scott Gottlieb: Tariffs are a very inefficient tool to reshore drug manufacturing (CNBC TV)
09:53AM	Stock Market Today: Dow Up After New Trump Tariffs; Novo Plunges On Drug Trial Results (Live Coverage) (Investor's Business Daily)
09:41AM	Stocks to Watch Monday: Novo Nordisk, Merck, Domino's, Gilead (The Wall Street Journal)
09:36AM	Why Novo Nordisk Stock Is Pluging-and Why It's Good News for Lilly (Barrons.com)
09:30AM	Instant View: Novo's CagriSema setback may shift investor focus to M&A strategy, analysts say (Reuters)
09:11AM	Weight-loss drug trial results wipe £147bn off Ozempic maker (The Telegraph)
09:03AM	Lilly to launch multi-dose weight-loss drug device in US (Reuters)
09:00AM	Investors Heavily Search Novo Nordisk A/S (NVO): Here is What You Need to Know (Zacks)
08:46AM	Stock Market Today: Dow Falls On New Trump Tariffs; Novo Plunges On Drug Trial Results (Live Coverage) (Investor's Business Daily)
08:41AM	Novo Nordisk's CagriSema falls short against Eli Lilly's in trial (Reuters Videos)
08:11AM	5 Things to Know Before the Stock Market Opens (Investopedia)
08:09AM	Novo Nordisk's next obesity drug falls short of Lilly rival, wiping billions off its market value (Proactive)
07:39AM	Novo Nordisk flags board members for re-election amid restructuring efforts (Pharmaceutical Technology)
07:04AM	Premarket movers: Novo Nordisk, Eli Lilly, Domino's Pizza and more (MarketWatch)
06:32AM	Novo Nordisk Stock Plunges and Eli Lilly Jumps. It's All Down to This Weight-Loss Drug Trial. (Barrons.com)

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Novo Nordisk A/S	10% Owner	May 30 '25	Proposed Sale	2.14	921,897	1,972,859		May 30 08:31 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVO

Novo Nordisk ADR

Upgrade your FINVIZ experience